{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6846e583cca944a48e6715d3/6ae893abb478422f91332d1a?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"CPHI Milan 2026: From 500 Million To A Billion Units - Ankit Gupta","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6846e583cca944a48e6715d3/1793626527099-8f30b783-927f-47fc-8b78-7571f30f8406.jpeg?height=200","description":"<p>95% of our viewers aren&#39;t subscribed. If you&#39;re watching and not yet subscribed, please subscribe to the channel so you don&#39;t miss future episodes.</p><p><br></p><p>Register your interest for 2027 here: https://www.cphi.com/europe/register-attend/?utm_source=partner&amp;utm_medium=referral&amp;utm_campaign=hln27cpw-cl-arto</p><p><br></p><p>A year ago, InstaPill was adding a new block to take its capacity in India to 500 million units. Now CEO Ankit Gupta plans a new greenfield site to double that to a billion, able to handle everything that is ODT.</p><p><br></p><p>This week on Making It In Manufacturing, Harry Sloan caught up again with Ankit Gupta, CEO of InstaPill, at CPHI Milan 2026, where ARTO was the official podcast partner.</p><p><br></p><p>In this episode, Ankit covers:</p><p><br></p><p>(01:12) Why InstaPill is planning a new greenfield site in India, on about 18 acres of land, modular so capacity can grow with demand.</p><p>(02:35) The move to a CDMO and B2B model, built on its two strengths: development and manufacturing.</p><p>(03:55) What sets InstaPill apart: transparency and flexibility, with projects partners typically do in 9 to 10 months delivered in 3 to 6.</p><p>(05:01) Where a US site fits: the bulk of its partners are in the US, and the plan stays on track for when partners need it.</p><p>(06:22) What to ask him about next year: more visible partnerships and more products reaching the market.</p><p><br></p><p>Watch the full episode to hear why Ankit wants partners to think of InstaPill as the company that can do everything that is possible on ODT.</p><p><br></p><p>Follow ARTO</p><p><br></p><p>LinkedIn: https://www.linkedin.com/company/artotalent/</p><p>Spotify: https://open.spotify.com/show/1cSZVJ63yXJ3kqnVORyTbw</p><p>Instagram: https://www.instagram.com/arto.talent</p><p>TikTok: https://www.tiktok.com/@artotalent</p><p>Apple Podcasts: https://podcasts.apple.com/gb/podcast/making-it-in-manufacturing/id1819731245</p><p>Website: https://arto-talent.com/</p><p>Youtube: https://www.youtube.com/@artotalent</p><p><br></p><p>Ankit Gupta</p><p>LinkedIn: https://www.linkedin.com/in/reachankit/</p><p><br></p><p>Harry Sloan</p><p>LinkedIn: https://www.linkedin.com/in/harry-sloan-605620154/</p><p><br></p><p>Timestamps:</p><p>00:00 Introduction</p><p>01:12 Doubling to a billion units</p><p>02:35 From own products to CDMO partner</p><p>03:55 Transparency and flexibility</p><p>05:01 The plan for the US</p><p>06:22 What to watch for next year</p><p><br></p><p>#MakingItInManufacturing #ARTOTalent #CPHI #CPHIMilan #ODT #CDMO #DrugDelivery #PharmaManufacturing</p>","author_name":"ARTO Talent"}